Egypt's most trusted pharma salary survey is open for 2026
Benchmark your compensation structure against 100+ Egyptian pharmaceutical companies. Make confident salary decisions backed by real, current local market data. Request survey overview
Every wrong salary decision has a hidden cost.
Without accurate compensation data, companies risk losing top talent, overpaying roles, and making increase decisions under pressure — with no market anchor.
Losing Key Talent
Top performers leave when competitors offer stronger packages — and you never see it coming until it's too late.
Payroll overspend
Paying above market without knowing it quietly reduces profitability. Market data reveals where every pound is justified.
Internal Pay Gaps
Unclear salary bands create fairness issues between teams, levels, and functions — damaging culture and engagement.
Rejected Offers
Weak compensation offers fail to close top candidates, lengthening time-to-hire and inflating recruitment costs.
A complete view of salary, benefits, and total compensation
The 2026 report gives your leadership team practical data points to support salary reviews, hiring offers, annual increases, and retention decisions.
P25 / P50 / P75 percentiles by job level and function
Annual bonus, QSI, commission structures by level
Car, medical, housing, and pharma field allowances
Fixed, variable, and non-cash — full CTC picture
See exactly where your packages stand vs. the market
MR → DSM → RSM → NSM → Country Manager benchmarks
Merit, COLA, and promotion data for 2025–2026
Practical HR guidance to act on data immediately
Built for the Egyptian pharmaceutical market.
Deep local expertise in pharma compensation benchmarking — covering field force, medical affairs, commercial, and corporate functions across all company types and segments.
Confidential, structured, and data-driven.
A professional six-step process designed to protect your company data while delivering meaningful, actionable market insights you can act on immediately.
Secure Participation
Companies submit compensation data through a controlled, confidential process with a signed data agreement.
Data Validation
All submissions are reviewed, cleaned, and checked for consistency before any analysis begins.
Job Matching
Roles and levels are calibrated to ensure accurate, like-for-like comparisons across all participating organisations.
Statistical Analysis
Salary percentiles, variable pay, benefits, and total compensation are rigorously analysed.
Final Report
Your team receives a clear, decision-ready report with benchmarks, market positioning, and context.
Consultation Session
Optional advisory support helps you translate survey results into a stronger total rewards strategy.
Designed for decision-makers who manage people, cost, and growth.
Our Clients
Get the 2026 salary survey overview
Fill in your details and our team will reach out within 1 business day with the full survey scope, participation process, and pricing.
Frequently asked questions.
s my company's data kept confidential?
Yes. All submitted data is handled securely under a signed confidentiality agreement. Published outputs are fully aggregated and anonymised — no individual company data ever appears in any report. A minimum of five companies is required before any data point is published.
What does the 2026 report include?
he report includes base salary benchmarks (P25 / P50 / P75) by job level and function, variable pay and incentive data, field force allowances, benefits prevalence and values, total cash compensation, total cost to company (CTC), salary increase trends, market positioning analysis, and practical HR recommendations.
Is the survey only for pharmaceutical companies?
The primary focus is the Egyptian pharmaceutical market — covering human pharma, OTC, generics, originator, biologics, medical devices, and veterinary. Customised benchmarking for adjacent healthcare sectors can be discussed with our team directly.
When will the 2026 report be delivered?
Data submission closes on 1 September 2026. The final report is scheduled for delivery in Q4 2026. Participating companies receive the report before general market availability.
Can Resources One help us interpret the results?
Yes. An optional consultation session can be arranged with our senior C&B consultants to help your leadership team translate survey findings into practical compensation decisions, salary review recommendations, and retention strategies.
How many companies participated in previous editions?
Resources One has been running the Egyptian pharma salary survey for over 14 years. The survey typically draws 100+ pharmaceutical companies across all segments, providing a statistically robust, market-representative benchmark you can trust.
Stop guessing. Start deciding with data.
Request your 2026 salary survey overview today and see exactly where your compensation structure stands against the Egyptian pharmaceutical market.
Request Salary Survey Overview